Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

KRX/005690 stock hub

KRX/005690 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KRX/005690is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.2T

Korea Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

KRX/005690

In the news

Latest news · KRX/005690

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.8P50 17.1P75 31.9

Trailing P/En/a

P25 12P50 23.1P75 39.5

ROE-29.3

P25 -17.1P50 0.7P75 8.5

ROIC-5.3

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KRX/005690 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

190

Groups with data

Currency

KRW

Showing 190 of 190 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Biotechnology
Isin	KR7005690003
Last refreshed	2026-05-10
Market cap	KRW 1.2T
Price	KRW 19,320
Price currency	KRW
Sector	Healthcare
Sic	2836
Symbol	krx/005690
Website	https://www.pharmicell.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.31%
FCF yield	-0.67%
P/B ratio	13.76x
P/S ratio	48.41x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-38.8%
EBITDA Margin	-25.83%
Gross margin	22.74%
Gross Profit	KRW 5.4B
Gross Profit Growth	11.45%
Gross Profit Growth3 Y	49.65%
Gross Profit Growth5 Y	7.53%
Net Income	KRW -26.8B
Net Income Growth Quarters	5%
Net Income Growth Years	2%
Pretax Margin	-111.71%
Profit Margin	-111.85%
Profitable Years	7
ROA	-4.98
Roa5y	-11.77
ROCE	-10.54
ROE	-29.25
Roe5y	-45.25
ROIC	-5.33

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	13.01%
Cagr15y	6.05%
Cagr1y	73.81%
Cagr20y	17.16%
Cagr3y	27.51%
Cagr5y	3.2%
Div CAGR10	9.6%
Div CAGR3	35.72%
Div CAGR5	20.11%
EPS Growth Quarters	5
EPS Growth Years	2
Revenue Growth	-3.6x
Revenue Growth Q	-58.16x
Revenue Growth Quarters	7x
Revenue Growth Years	2x
Revenue Growth3 Y	53.69x
Revenue Growth5 Y	17.85x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.21
Assets	KRW 102.2B
Cash	KRW 9.4B
Current Assets	KRW 18.7B
Current Liabilities	KRW 14B
Debt	KRW 11.7B
Debt Equity	KRW 0.14
Debt FCF	KRW -1.5
Equity	KRW 84.3B
Interest Coverage	-7.48
Liabilities	KRW 17.9B
Long Term Assets	KRW 83.4B
Long Term Liabilities	KRW 3.9B
Net Cash	KRW -2.3B
Net Cash By Market Cap	KRW -0.2
Net Debt Equity	KRW 0.03
Tangible Book Value	KRW 49.5B
Tangible Book Value Per Share	KRW 1,097
WACC	8.12

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.34
Inventory Turnover	5.05
Net Working Capital	KRW 7B
Quick ratio	1.05
Working Capital	KRW 4.7B
Working Capital Turnover	KRW 10.11

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-7.56%
Dividend Growth	150%
Dividend Growth Years	1%
Dividend per share	KRW 50
Dividend Years	2
Dividend Yield	0.26%
Ex Div Date	2025-12-29
Last Dividend	KRW 50
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	239.8%
1Y total return	73.74%
200-day SMA	14,832.8
3Y total return	107.37%
50-day SMA	16,774.6
50-day SMA vs 200-day SMA	50over200
5Y total return	17.03%
All Time High	26,350
All Time High Change	-26.68%
All Time High Date	2018-04-10
All Time Low	141.2
All Time Low Change	13,582.62%
All Time Low Date	1998-08-18
ATR	1,315.5
Beta	0.7
Beta1y	1.4
Beta2y	1.32
Ch YTD	32.97
High	20,350
High52	21,150
High52 Date	2026-05-04
High52ch	-8.65%
Low	18,650
Low52	10,360
Low52 Date	2025-06-23
Low52ch	86.49%
Ma50ch	15.17%
Price vs 200-day SMA	30.25%
RSI	56.46
RSI Monthly	68.54
RSI Weekly	62.89
Sharpe ratio	1.16x
Sortino ratio	2.12
Total Return	-7.3%
Tr YTD	32.97
Tr15y	141.46%
Tr1m	32.69%
Tr1w	-4.59%
Tr3m	44.29%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW -9.3B
Operating margin	-38.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	52,981,980%
Net Borrowing	-8,921,492,080
Shares Insiders	11.47%
Shares Institutions	4.83%
Shares Out	60,004,014
Shares Qo Q	1.98%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -8.1B
Average Volume	1,524,076.2x
Bv Per Share	1,867.9
CAPEX	KRW -272.7M
Ch10y	238.9
Ch15y	127.3
Ch1m	32.69
Ch1w	-4.59
Ch1y	73.74
Ch20y	2,133.5
Ch3m	44.29
Ch3y	106.9
Ch5y	16.74
Ch6m	11.68
Change	1.15%
Change From Open	2.88
Close	19,100
Days Gap	-1.68
Depreciation Amortization	3,106,249,000
Dollar Volume	25,609,278,240
EBIT	KRW -9.3B
EBITDA	KRW -6.2B
EPS	KRW -614
F Score	3
FCF	KRW -7.8B
FCF Per Share	KRW -130
Financing CF	-1,921,522,540
Fiscal Year End	December
Founded	1,968
Goodwill	34,551,014,000
Investing CF	10,511,746,100
Is Primary Listing	1
Last Report Date	2014-06-30
Last Split Date	2011-12-01
Last Split Type	Forward
Ma150	15,741.8
Ma150ch	22.73%
Ma20	18,545
Ma20ch	4.18%
Net CF	1,043,025,740
Open	18,780
Payment Date	2026-04-24
Position In Range	39.41
Ppne	4,568,253,000
Price Date	2026-05-08
Ptbv Ratio	23.41
Relative Volume	0.87x
Revenue	23,944,797,270x
SBC By Revenue	1.05x
Share Based Comp	250,325,000
Tr20y	2,272.71%
Tr6m	11.68%
Volume	1,325,532
Z Score	4.6

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

KRX/005690 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.3%

$50.0 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+20.1%

1 consecutive years of growth

Total shareholder yield

-7.3%

Next ex-dividend date: 2025-12-29

Performance

KRX/005690 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KRX/005690?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.8%

Share of float held by funds and institutions

Insider ownership

+11.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

KRX/005690 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.5

Neutral momentum band

Price vs 200-day MA

+30.3%

50/200-day relationship not available

Beta (5Y)

0.70

Less volatile than the market

Sharpe ratio

1.16

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KRX/005690

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/005690 stock rating?

krx/005690 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/005690 analysis?

The full report lives at /stocks/krx/005690/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/005690?

The latest report frames krx/005690 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/005690 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.